Doctor Masaki Shimizu
Sapporo Medical University, Sapporo (Japan)
Rapamycin ameliorates doxorubicin-induced cardiomyopathy through suppression of RIPK1-independent necroptosis
Event: ESC Congress 2023
Topic: Drugs, Drug Targets
Session: Molecular cardio-oncology
Nuclear accumulation of MLKL induces necroptosis in cardiomyocytes: potential implication in Doxorubicin-induced cardiotoxicity.
Event: ESC Congress 2022
Topic: Drugs, Drug Targets
Session: Acquired forms of heart failure: cancer and inflammatory disorders
ESC 365 is supported by
